Adverse Events of Factor Xa Inhibitors in Pediatric Patients: A Meta-analysis and Pharmacovigilance Study: S. Chong et al.
1. 系统已在2026-05-19 15:27:56对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
S Chong, L Sun, G Mu, M Hua, Q Xiang, Y Cui
Pediatric Drugs, 2025
Springer
… LMWH has become the primary anticoagulant of choice for pediatric patients, with guidelines recommending target anti-Xa levels … of myocardial infarction in young children and infants. …

